BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Helix BioPharma Corp. Closes Private Placement

  Helix BioPharma Corp. announced it has closed a private placement financing for gross proceeds of CAD750,600.

  December 22, 2017

   · 

  3 min read
• Drug Development

  Clover Biopharmaceuticals Receives CFDA Approval to Initiate Clinical Trials in China with Etanercept Biosimilar Candidate SCB-808

  A phase I clinical trial is planned to initiate in China in mid-2018.

  December 22, 2017

   · 

  2 min read
• Business

  Humanigen Signs Definitive Agreements to Exchange Loan Obligations for Equity

  The transactions are expected to close in the first quarter of 2018 subject to the satisfaction of certain conditions contained in the definitive agreements.

  December 22, 2017

   · 

  7 min read
• Forward Pharma Files Final Brief in its Appeal of the U.S. Patent Interference to the Federal Circuit

  Forward Pharma today announced the filing of its reply brief to the U.S. Court of Appeals for the Federal Circuit in the appeal of the PTAB’s decision in the interference proceeding between the Forward 11/576,871 patent application and an issued Biogen patent.

  December 22, 2017

   · 

  3 min read
• Xbrane Biopharma Largest Shareholder Serendipity Group Issues a Credit Facility Of SEK 50 Million to the Company

  The Credit Facility can be utilized by the Company over a period of 18 months.

  December 22, 2017

   · 

  2 min read
• Deals

  Centinel Spine Completes Acquisition of Prodisc Assets

  Centinel Spine is pleased to announce the acquisition of the worldwide assets of the prodisc Total Disc Replacement portfolio from DePuy Synthes The prodisc line of products are total disc replacement products with the longest history of use globally.

  December 22, 2017

   · 

  3 min read
• Pharm Country

  Tauriga Sciences Extinguishes its Largest Remaining Balance Sheet Liability for One Time Cash Payment of $15,000 and One Time Issuance of 5,000,000 Restricted Shares; Liability Dated Back to the Years 2010/2011 and Totaled $177,883.71

  This Accounts Payable liability totaled $177,883.71 and the creditor was a U.S. based Environmental Engineering firm.

  December 22, 2017

   · 

  4 min read
• Business

  Haemonetics Sets Date for Publishing Third Quarter Fiscal 2018 Results: February 6, 2018

  Haemonetics announced that the Company intends to publish third quarter fiscal 2018 financial results at 6:00 am Eastern Time on Tuesday, February 6, 2018.

  December 22, 2017

   · 

  1 min read
• Business

  GBT Appoints Wendy L. Yarno to Board of Directors

  Ms. Yarno has more than 25 years of experience in the biopharmaceutical industry, including serving as chief marketing officer at Merck.

  December 22, 2017

   · 

  6 min read
• BioMidwest

  SAB Biotherapeutics Launches Utah-Based Subsidiary SAB Capra, LLC.

  SAb Biotherapeutics announced today they have formed and officially launched a Utah-based wholly owned subsidiary, SAB Capra, LLC and incorporated the new entity under the SAB Biotherapeutics corporate umbrella.

  December 22, 2017

   · 

  4 min read